This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 18 and 60
years old
The phase for this study is not defined.
Show me locations

The purpose

The primary aim of this study is to examine the effect of acute ingestion of fructose on serum FGF21 levels. Subjects in this study will be lean volunteers and individuals with metabolic syndrome.

Provided treatments

  • : oral carbohydrate challenge

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02884791. The sponsor of the trial is Beth Israel Deaconess Medical Center and it is looking for 50 volunteers for the current phase.
Official trial title:
Fibroblast Growth Factor 21 and Fructose Challenge in Humans